Synthesis of Cannabinol by a Modified Ullmann–Ziegler Cross-Coupling

Abstract

Cannabinol, a pharmaceutically interesting component of cannabis, was prepared by a modified Ullmann–Ziegler cross-coupling. Using easily obtainable starting materials, this convergent approach allows facile access to a variety of cannabinol derivatives.

Key words

natural products - cross-coupling - palladium - copper - cannabinoids

• References and Notes

• 1 Martin BR, Lichtman AH. Neurobiology of Disease 1998; 5: 447
• 2 Pertwee RG. Euphytica 2004; 140: 73
• 3 Mechoulam R. Br. J. Pharmacol. 2005; 146: 913
• 4 Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutiérrez SO, van der Stelt M, López-Rodriguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C, Lutz B. Science 2003; 302: 84
• 5 Eubanks LM, Rogers CJ, Beuscher AE. IV, Koob GF, Olson AJ, Dickerson TJ, Janda KD. Mol. Pharmacol. 2006; 3: 773
• 6a Tashkin DP, Shapiro BJ, Lee YE, Harper CE. Am. Rev. Respir. Dis 1975; 112: 377
• 6b Di Carlo G, Izzo AA. Expert Opin. Invest. Drugs 2003; 12: 39
• 6c Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard J.-L, Mach F. Nature 2005; 434: 782
• 6d Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL. Neurology 2007; 68: 515
• 6e McAllister SD, Christian RT, Horowitz MP, Garcia A, Desprez P.-Y. Mol. Cancer Ther. 2007; 6: 2921
• 7a Mackie K. J. Neuroendocrinol. 2008; 20: 10
• 7b Howlett AC. Prostaglandins Other Lipid Mediat. 2002; 68-69: 619-631
• 8 Elphick MR, Egertova M. Philos. Trans. Roy. Soc. B 2001; 356: 381
• 9a Marriott K.-SC, Huffman JW. Curr. Top. Med. Chem. 2008; 8: 187
• 9b Pertwee RG. Pharmacol. Ther. 1997; 74: 129
• 10 Mahadevan A, Siegel C, Martin BR, Abood ME, Beletskaya I, Razdan RK. J. Med. Chem. 2000; 43: 3778
• 11a Abood ME, Martin BR. Trends Pharmacol. Sci. 1992; 13: 201
• 11b Ameri A. Progress in Neurobiology 1999; 58: 315
• 12 McCallum ND, Yagen B, Levy S, Mechoulam R. Experientia 1975; 31: 520
• 13 Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I. Forensic Toxicol. 2006; 24: 80
• 14 Novak J, Salemink CA. J. Chem. Soc., Perkin Trans. 1 1983; 2867
• 15 Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, Smith E, Rahman MM. J. Nat. Prod. 2008; 71: 1427
• 16a Adams R, Baker BR. J. Am. Chem. Soc. 1940; 62: 2401
• 16b Mechoulam R, Braun P, Gaoni Y. J. Am. Chem. Soc. 1972; 94: 6159
• 16c Mechoulam R, Braun P, Gaoni Y. J. Am. Chem. Soc. 1967; 89: 4552
• 16d Rhee M.-H, Vogel Z, Barg J, Bayewitch M, Levy R, Hanuš L, Breuer A, Mechoulam R. J. Med. Chem. 1997; 40: 3228
• 17a Khanolkar AD, Lu D, Ibrahim M, Duclos JI, Thakur GA, Malan JP, Porreca F, Veerappan V, Tian X, George C, Parrish DA, Papahatjis DP, Makriyannis A. J. Med. Chem. 2007; 50: 6493
• 17b Hattori T, Suzuki T, Hayashizaka N, Koike N, Miyano S. Bull. Chem. Soc. Jpn. 1993; 66: 3034
• 17c Novak J, Salemink CA. Tetrahedron Lett. 1982; 23: 253
• 18 Nüllen MP, Göttlich R. Synthesis 2011; 1249
• 19 Typical Procedure: The resorcinol derivate (2 equiv) and anhydrous TMEDA (2 equiv) were dissolved in anhydrous 1,2-dimethoxyethane (DME) and cooled to 0 °C before adding n-butyllithium (2.5 M in hexanes, 2.2 equiv) by using a syringe. The mixture was stirred for 1.5 h then CuBr·SMe₂ (1 equiv) was added and stirring was continued for 30 min. [Pd(PPh₃)₄] (7.5 mol%), aryl iodide (1 equiv) and anhydrous NMP were added and the reaction mixture was heated for 12 h in a sealed Schlenk tube. The reaction was quenched by the addition of saturated aqueous NH₄Cl solution, followed by extraction of the aqueous layer with MTBE (3×). The combined organic layers were washed with concentrated aqueous NH₃ solution and brine, before being dried with MgSO₄. After removal of the solvents, the desired biphenyl compound was isolated by flash chromatography.